SPATIAL SEPARATION OF PARTICLES IN A PARTICLE CONTAINING SOLUTION FOR BIOMEDICAL SENSING AND DETECTION
20220113293 · 2022-04-14
Inventors
Cpc classification
B01L2300/06
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0864
PERFORMING OPERATIONS; TRANSPORTING
B01L2200/0647
PERFORMING OPERATIONS; TRANSPORTING
B01L2300/0861
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502715
PERFORMING OPERATIONS; TRANSPORTING
G01N1/4077
PHYSICS
B01L2300/0816
PERFORMING OPERATIONS; TRANSPORTING
B01L2400/0436
PERFORMING OPERATIONS; TRANSPORTING
B01L3/502761
PERFORMING OPERATIONS; TRANSPORTING
International classification
Abstract
A device and method for analyte detection and analytes in a particulate bearing fluid such as whole blood having an instrument for partitioning the panicles from the fluid that is integrated with a detector for analyses of one or more particulate bearing fluid analytes while the particles in the particulate bearing fluid are partitioned.
Claims
1-10. (canceled)
11. A system comprising: a channel to receive blood comprised of blood cells and plasma, the blood being part of a sample having a volume of 1 microliter (μl) or more; an acoustic transducer in contact with the channel to generate acoustic waves that apply acoustic force to the blood in the channel to form a fluid layer in the channel and two particle layers in the channel, the fluid layer being between the two panicle layers in the channel, the fluid layer comprising the plasma, and the fluid layer being substantially free of the blood cells, the acoustic waves having frequencies in a range of 2 kilohertz (KHz) to 2 gigahertz (GHz); wherein the fluid layer is formed in an area of the channel that aligns with an optical detector configured to detect an attribute of the blood based on a measurement performed on the fluid layer, and wherein the acoustic transducer is configured to stop the acoustic force and, in response to stoppage of the acoustic force, at least part of the blood reconstitutes downstream of a region where the attribute is detected.
12. The system of claim 11, wherein the attribute is based on cells in the blood.
13. The system of claim 11, wherein the attribute comprises hemoloysis
14. The system of claim 11, wherein the attribute comprises a pathogen associated with the blood.
15. The system of claim 11, wherein the fluid layer is arrested in the region when the attribute is detected. cm 16. The system of claim 11, wherein the fluid layer is flowing in the region when the attribute is detected.
17. The system of claim 11, wherein the channel is configured for fluid communication with a sample port through which the blood moves into the channel.
18. The system of claim 19, wherein the microchannel comprises light-transmissible material.
19. A system comprising: a first channel to receive blood comprised of blood cells and plasma, the blood being part of a sample having a volume of 1 microliter (μl) or more. an acoustic transducer in contact with the channel to generate acoustic waves that apply acoustic force to the blood in the channel to form layers in the channel, the layers comprising a fluid layer and a particle layer, the fluid layer comprising the plasma, the fluid layer being substantially free of the blood cells, and the particle layer comprising the blood cells, the acoustic waves having frequencies in a range of 2 kilohertz (KHz) to 2 gigahertz (GHz), wherein the fluid layer is formed in an area of the channel that aligns with an optical detector configured to detect an attribute of the blood based on a measurement performed on the fluid layer, and second channels that are downstream of the first channel and that branch-off from the first channel such that all content of the first channel flow's into the second channels, a first one of the second channels to receive the fluid layer and a second one of the second channels to receive the particle layer.
20. The system of claim 19, wherein the attribute is based on cells in the blood.
21. The system of claim 19, wherein the attribute comprises hemoloysis.
22. The system of claim 19, wherein the attribute comprises a pathogen associated with the blood.
23. The system of claim 19, wherein the fluid layer is arrested in the region when the attribute is detected.
24. The system of claim 19, wherein the fluid layer is flowing in the region when the attribute is detected.
25. The system of claim 19, wherein the channel is configured for fluid communication with a sample port through which the blood moves into the channel.
26. A system comprising: a channel to receive a substance comprised of particles and fluid; an acoustic transducer to generate acoustic waves that apply acoustic force to the substance in the channel to separate the particles and the fluid within the channel, the acoustic force causing the particles to aggregate in a center of the channel and the fluid to move toward walls that define boundaries of the channel, the acoustic waves having frequencies in a range of 2 kilohertz (KHz) to 2 gigahertz (GHz); wherein, while the acoustic force is applied, flow of the panicles is arrested in a region of the channel where the acoustic force is applied, and wherein the acoustic transducer is configured to stop the acoustic force and, in response to stoppage of the acoustic force, an entirety of the substance reconstitutes downstream of the region of the channel where the acoustic force is applied.
27. The system of claim 26, wherein the particles comprise blood cells.
28. The system of claim 26, wherein the particles comprise bacteria.
29. The system of claim 26, wherein the particles comprise a pathogen.
30. The system of claim 26, wherein the microchannel comprises light-transmissible material.
Description
BRIEF DESCRIPTION OF THE FIGURES
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
DESCRIPTION OF THE INVENTION
[0040] The invention described below is directed to a system and a method for detecting and measuring analytes in whole blood by integrating a microfluidic device, acoustic transducers and a detection apparatus for a wide range of needs for analyzing analytes in a complex fluid, such as whole blood and other fluids, that include particles in the size range of a few nanometers to hundreds of microns. Target analytes include but are not limited to glucose, lactate, sodium, potassium, chloride, hemoglobin, troponin l, cholesterol, and coagulation factors.
[0041] The invention disclosed herein has at least the following advantages over existing systems for detecting and measuring analytes in whole blood including but not limited to, free hemoglobin. Hemoglobin may be used as an indicator of hemolysis in the blood sample undergoing analysis. [0042] a one step, single integrated device for enhanced particulate partitioning efficiency in a particulate-bearing fluid by application of a continuous acoustic force in a localized area of the fluid while flow is arrested, or alternatively, while fluid is flowing and measuring an analyte by a detector in the fluid from which the particles are partitioned from the arrested or flowing fluid; [0043] one step partitioning of particulates and fluid in a flowing or arrested sample, i.e., single stage partitioning of particles, e.g., cells, and no need for multi-stage separation that is used for “separation while flowing”; [0044] elimination of a separate device, for example, a centrifuge or filters to collect plasma for analytical measurement, or a separate analyte detection device into which the collected plasma is analyzed; [0045] reversibility of partitioned particles, e.g., red blood cells (RBCs), to reconstitute whole blood thereby maintaining blood integrity, e.g., hematocrit, blood constituents, RBC integrity, after application of acoustic forces and after analyte analysis; [0046] reusability of the whole blood sample (because of particulate partitioned reversibility) without the need for additional remixing of plasma and RBCs for other whole blood measurements, e.g., whole blood viscosity; [0047] small sample volume required for analysis in a range of 1 microliter to 10 milliliters; [0048] simplicity of manufacture and operation of acoustics, fluidics, and detectors, e.g., optical detectors in the microfluidic device according to the invention.
[0049] A significant advantage of the invention disclosed herein is a device and method for the partitioning of plasma from a whole blood sample, analyte detection in the sample in one step: no need to collect plasma first and then perform analysis on collected plasma. In a microchannel, plasma is reversibly separated and not collected from the cellular content of whole blood. The separated plasma is analyzed in an integrated detector without a collecting step or a step requiring collected plasma analysis in a separate independent clinical analyzer for the analyte of interest.
[0050] As used herein, a particle refers to any particulate matter in a size range from 10 nm to 1.5 millimeters including but not limited to cells such as red blood cells, white blood cells, platelets, bacteria, viruses and other pathogens.
[0051] A particular non-limiting application of the disclosed system for analysis of a complex particle-bearing fluid pertains to clinical diagnostics in the field of healthcare. For example, the invention described herein eliminates the need for centrifuging or filtering a patient's whole blood sample to achieve plasma separation and plasma collection in a container other than the microchannel in which a whole blood sample is held. The system according to the invention improves sample throughput by eliminating the requirement for additional instrumentation, e.g., an independent detector in a clinical analyzer, or centrifuge in the point-of-care environment such as in the emergency, cardiac care, or critical care room, or in military hospitals in the field.
[0052] According to the invention, and referring to one embodiment illustrated in
[0053] In a particular embodiment, an arrested flow mode, in contrast to a continuous flow method, enhances the efficiency of particulate partitioning and integration of an on-chip detection apparatus. In this embodiment, the system 10 according to the invention includes a fluid flow arrestor (not shown) for arresting the flow of fluid such as blood in the separation/detection microchannel 12 by hardware, such as but not limited to pumps, valves, flow regulators, compressors and processors (not shown) for a defined period of time while the acoustic force is applied to the arrested particulate bearing fluid sample in the microchannel 12. Arrested blood flow increases residence time of the sample in the applied acoustic field. Continuous separation of the particles in a designated area, i.e., a detection region of the microchannel, is achieved.
[0054] Additionally, by releasing the acoustic forces on the fluid sample, the partitioning of particles in the complex fluid medium is reversible, thereby reconstituting the particles, such as cells, in the complex fluid medium, such as plasma, to reconstitute whole blood for further analysis. The reconstituted whole blood may be captured in a collector positioned in fluid communication with the microchannel 12 in a reservoir such as but not limited to another microchannel, a pocket, a dilatation, a chamber, or a cavity. Thus, the system 10 according to the invention is readily applicable to point-of-care applications as well as in a central clinical laboratory.
[0055] Additionally, the system according to the invention 10 may be incorporated into the extracorporeal blood line of a heart/lung machine for continuous monitoring of blood analytes during a surgical procedure requiring cardiopulmonary bypass such as but not limited to cardiac valve repair or replacement, pulmonary thrombectomy, repair of septal defects, congenital cardiac or vascular defects, and thromboendarterectomy. The system according to the invention may be used in the extracorporeal blood line of infants with serious congenital defects receiving life support or to oxygenate blood to maintain patients in need of and waiting for an organ transplant.
[0056] In addition to detection of hemolysis, the system and method according to the invention can also be used in the following fields: [0057] particle based chemical assays using reporter beads, such as bead-based virus detection, or bacteria detection, for example [0058] other cell based assays using cell suspensions, such as detection of circulating tumor cells (CTC) in a blood sample, other body fluid samples, or cell fractions obtained from a tissue such as but not limited to a neoplasm
Examples of the Various Embodiments of the System According to the Invention
[0059]
[0060] With continued reference to
[0061] As described above, by releasing acoustic forces on the fluid sample, the partitioning of RBCs is reversible permitting the reconstitution of whole blood that may be collected in a downstream collector such as, for example, a tube, vessel, bag, or chamber for collecting and holding whole blood.
[0062]
[0063] Detectors 19 such as optical detectors/transmitters, or sensors such as traditional photometry detection apparatus, traditional fluorescence measurement systems, time resolved fluorescence measurement system, which usually includes LEDs, spectrometers, photodiodes and related optics, are located at a detector region 18 in the microchannel 12 for detection of the analyte of interest.
[0064] In this embodiment, shown in
[0065] Analysis by the detector 19 is performed on the substantially particle-free fluid 28 while flow is arrested or, alternatively, while the substantially panicle-free fluid 28 is moving in the microchannel 12. Detectors 19 including optical detectors/transmitters, or sensors such as traditional photometry detection apparatus, traditional fluorescence measurement systems, time resolved fluorescence measurement system, which usually includes LEDs, spectrometers, photodiodes and related optics, are integrated with the acoustic transducers 20 at the detector region 18 in the microchannel 12 for detection of the analyte of interest.
[0066]
[0067] As described above, by releasing acoustic forces on the fluid sample, the partitioning of RBCs is reversible permitting the reconstitution of whole blood that may be collected in a downstream collector such as for example, a tube, vessel, bag or chamber for collecting and holding whole blood.
[0068]
[0069] In this embodiment, shown in
[0070] Analysis by the detector 19 is performed on the substantially particle-free fluid 28 while flow is arrested or, alternatively, while substantially particle-free fluid 28 is moving in the microchannel 12.
[0071]
[0072] The analyte detection is performed in the regions of cell-free plasma. The detector 19 such as optical detectors/transmitters, or sensors such as traditional photometry detection apparatus, traditional fluorescence measurement systems, time resolved fluorescence measurement system, which usually includes LEDs, spectrometers, photodiodes and related optics, are integrated with the acoustic transducers 20 at the detector region 18 in the microchannel 12 for detection of the analyte of interest.
[0073] As described above, by releasing acoustic forces on the fluid sample, the partitioning of RBCs is reversible permitting the reconstitution of whole blood that may be collected in a downstream collector such as, for example, a tube, vessel, bag or chamber for collecting and holding whole blood.
[0074]
[0075] In this embodiment, the complex fluid 16 is introduced via a sample port 14 in fluid communication with a microchannel 12. The complex fluid 16 tills and forms a fluid column 26 within the microchannel 12. Acoustic transducers 20a and 20b are located at acoustic regions 21a, 21b, respectively for transmitting acoustic waves 24a, 24b, respectively into the column of the complex fluid 16, whole blood for example.
[0076] RBCs are moved by acoustic forces 24a towards the walls 11 of the microchannel 12. As the fluid flows further down the microchannel 12, the RBCs partitioned by acoustic forces 24a move out of microchannel 12 into one or more particle outlet channels 42a, 42b (42n). As illustrated in
[0077] After generation of a first substantially particle-free fluid 28a by partitioning the particles 27 in the first microchannel 12a at the first acoustic region 21a, by the application of an acoustic force 24, a substantially particle free portion flows into the second microchannel 12b and the particles are further partitioned from the fluid column 26 by the second acoustic transducer 20b in the second acoustic region 21b of the second microchannel 12b. In this embodiment of the system 10, the particles in the complex fluid such as whole blood are further partitioned by acoustic forces 24b in the second acoustic region 21b to obtain a further substantially particle-free fluid, such as plasma, for detection and analysis of a target analyte. Analysis by a detector 19 is performed on the second particle-free fluid 28b in the detector region 18 while the fluid is flowing or arrested after passing through the first acoustic region 21a and second acoustic region 21b.
[0078] Detector 19 such as optical detectors/transmitters, or sensors such as traditional photometry detection apparatus, traditional fluorescence measurement systems, time resolved fluorescence measurement system, which usually includes LEDs, spectrometers, photodiodes and related optics, are located in a detector region 18 of the second microchannel 12b at the acoustic region 21b immediately downstream for detection of the analyte of interest in the second particle free fluid 28b.
[0079]
[0080] In the embodiment shown in
[0081] In the embodiment illustrated in
[0082] Analysis by the detector 19 at a location downstream from the acoustic regions 21n can be performed on the substantially particle-free fluid 28 while the fluid is flowing or arrested. Detectors 19 such as optical detectors/transmitters, or sensors such as traditional photometry detection apparatus, traditional fluorescence measurement systems, time resolved fluorescence measurement system, which usually includes LEDs, spectrometers, photodiodes and related optics, are located at a detector region in the microchannel for detection of the analyte of interest.
[0083] As described above, by releasing acoustic forces on the fluid sample, the partitioning of RBCs is reversible permitting the reconstitution of whole blood that may be collected in a downstream collector such as, for example, a tube, vessel, bag or chamber for collecting and holding whole blood.
[0084]
[0085] In this embodiment, the complex fluid 16 is introduced via a sample port 14 in fluid communication with a microchannel 12. The complex fluid 26 fills and forms a fluid column 26 within the microchannel 12.
[0086]
[0087] Analysis by the detector 19 can be performed on the substantially particle-free fluid 28 while fluid is flowing or arrested. Detectors 19 such as optical detectors/transmitters, or sensors such as traditional photometry detection apparatus, traditional fluorescence measurement systems, time resolved fluorescence measurement system, which usually includes LEDs, spectrometers, photodiodes and related optics, are located at a detector region 18 in the microchannel for detection of the analyte of interest.
[0088] As described above, by releasing acoustic forces on the fluid sample, the partitioning of RBCs is reversible permitting the reconstitution of whole blood that may be collected in a downstream collector such as, for example, a tube, vessel, bag or chamber for collecting and holding whole blood.
[0089]
[0090] In the embodiment illustrated in
[0091] Detector 19 such as optical detectors/transmitters, or sensors such as traditional photometry detection apparatus, traditional fluorescence measurement systems, time resolved fluorescence measurement system, which usually includes LEDs, spectrometers, photodiodes and related optics, are located at a detector region 18 in the microchannel 12 for detection of the analyte of interest. The particle-free fluid such as plasma flows through a plasma channel to a plasma outlet port 38 that is separate from particulate outlet ports 42a, 42b.
[0092] In yet another embodiment of the invention, multiple detector regions 18n in the microchannel 12 described in the above embodiments are associated with an acoustic device 20 and a detector 19 for analysis of multiple target analytes in a complex fluid such as whole blood, each target analyte being detected at one of the detector regions 18n.